A new preprint study by Dr. David Wiseman, CEO of Synechion, Inc., examines how flaws in FDA and CDC monitoring of VAERS may have led to massive safety signal loss for COVID-19 vaccines, including myocarditis, strokes, clotting, neurological symptoms, and more. He highlights serious flaws in current detection methods.
In this episode of the React19 podcast Dr. Wiseman’s reviews his study:
“Safety signal loss and underestimation of potential risks and suspected adverse reactions due to truancy, masking, and filtering in FDA’s analysis of VAERS data associated with COVID-19 pro-vaccines.”
Dr. Wiseman highlights the importance of transparency, rigorous analysis, and support for vaccine-injured individuals, calling for improved regulatory oversight and open scientific dialogue to ensure public safety and trust.
Dr. Wiseman is the founder and CEO of Synechion and has been working in the field since 1996 as a PhD Research Bio scientist with a background in pharmacy, pharmacology, immunology, and experimental pathology. He was one of the top 66 research scientists at Johnson & Johnson, where he headed up a research and development program overseeing preclinical and international clinical research, including pharmacovigilance.
2-Minute short summary of Dr. Wiseman’s paper:
https://x.com/AdhesionsOrg/status/1965508942672658747
Full video:
https://x.com/i/status/1965508942672658747
Link to preprint:
Link to information on Dr. Wiseman’s "Great Expectations" paper
https://x.com/AdhesionsOrg/status/1967989371203883103
Link to the preprint:
Contact Dr. Wiseman here:
If interested in supporting Dr. Wiseman’s work:
david.wiseman@synechion.com